Effects of Oral Levosimendan (ODM-109) on Respiratory Function in Patients With ALS
Clinical trial NCT03505021 · COMPLETED
Trial details
- NCT number
- NCT03505021
- Sponsor
- Orion Corporation, Orion Pharma
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-06-21
- Primary completion
- 2020-07-23
- Enrollment
- 496
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.